Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-08 5:17 pm Purchase | 2026-06-04 | 13G | FORTE BIOSCIENCES INC FBRX | Millennium Management LLC | 1,062,182 5.200% | 1,062,182![]() (New Position) | Filing History |
| 2026-05-15 4:34 pm Purchase | 2026-03-31 | 13G | FORTE BIOSCIENCES INC FBRX | ORBIMED ADVISORS LLC | 884,230 4.300% | 374,230![]() (+73.38%) | Filing History |
| 2026-05-15 4:29 pm Sale | 2026-03-31 | 13G | FORTE BIOSCIENCES INC FBRX | Point72 Asset Management, L.P. | 0 0.000% | -792,976![]() (Position Closed) | Filing History |
| 2026-05-15 4:09 pm Purchase | 2026-03-31 | 13G | FORTE BIOSCIENCES INC FBRX | MPM BioImpact LLC | 1,000,682 7.200% | 1,000,682![]() (New Position) | Filing History |
| 2026-05-15 4:05 pm Sale | 2026-03-31 | 13G | FORTE BIOSCIENCES INC FBRX | Alger Associates, Inc. | 1,272,596 10.200% | -361,671![]() (-22.13%) | Filing History |
| 2026-05-15 12:36 pm Sale | 2026-03-31 | 13G | FORTE BIOSCIENCES INC FBRX | Janus Henderson Group plc JHG | 1,387,178 9.990% | -38,607![]() (-2.71%) | Filing History |
| 2026-05-14 4:15 pm Purchase | 2026-03-31 | 13G | FORTE BIOSCIENCES INC FBRX | Affinity Asset Advisors, LLC | 1,011,890 7.300% | 176,926![]() (+21.19%) | Filing History |
| 2026-05-13 09:14 am Purchase | 2026-03-31 | 13G | FORTE BIOSCIENCES INC FBRX | Adage Capital Management, L.P. | 950,000 6.840% | 950,000![]() (New Position) | Filing History |
| 2026-02-17 4:35 pm Purchase | 2025-12-31 | 13G | FORTE BIOSCIENCES INC FBRX | Janus Henderson Group plc JHG | 1,425,785 11.400% | 768,276![]() (+116.85%) | Filing History |
| 2026-01-29 7:57 pm Sale | 2026-01-22 | 13G | FORTE BIOSCIENCES INC FBRX | Affinity Asset Advisors, LLC | 834,964 6.700% | -27,436![]() (-3.18%) | Filing History |
| 2026-01-20 4:51 pm Purchase | 2026-01-12 | 13G | FORTE BIOSCIENCES INC FBRX | Point72 Asset Management, L.P. | 792,976 6.300% | 792,932![]() (+1802118.18%) | Filing History |
| 2026-01-09 6:19 pm Sale | 2026-01-08 | 13G | FORTE BIOSCIENCES INC FBRX | Oliveira Steven Michael | 300,100 2.400% | -132,176![]() (-30.58%) | Filing History |
| 2025-12-23 5:15 pm Purchase | 2025-12-17 | 13G | FORTE BIOSCIENCES INC FBRX | Affinity Asset Advisors, LLC | 862,400 6.900% | 862,400![]() (New Position) | Filing History |
| 2025-11-14 4:08 pm Sale | 2025-09-30 | 13G | FORTE BIOSCIENCES INC FBRX | BIOTECHNOLOGY VALUE FUND L P | 65,350 0.500% | -578,272![]() (-89.85%) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | FORTE BIOSCIENCES INC FBRX | Alger Associates, Inc. | 1,634,267 13.100% | 15,618![]() (+0.96%) | Filing History |
| 2025-10-07 11:08 am Purchase | 2025-09-30 | 13G | FORTE BIOSCIENCES INC FBRX | FEDERATED HERMES INC. FHI | 1,635,380 13.150% | 156,733![]() (+10.60%) | Filing History |
| 2025-09-05 09:38 am Purchase | 2025-08-31 | 13G | FORTE BIOSCIENCES INC FBRX | FEDERATED HERMES INC. FHI | 1,478,647 11.890% | 406,414![]() (+37.90%) | Filing History |
| 2025-08-14 4:27 pm Purchase | 2025-06-30 | 13G | FORTE BIOSCIENCES INC FBRX | Alger Associates, Inc. | 1,618,649 13.300% | 708,040![]() (+77.75%) | Filing History |
| 2025-08-14 4:20 pm Purchase | 2025-06-30 | 13G | FORTE BIOSCIENCES INC FBRX | Ikarian Capital, LLC | 617,667 4.990% | 8,442![]() (+1.39%) | Filing History |
| 2025-08-14 11:46 am Unchanged | 2025-06-30 | 13G | FORTE BIOSCIENCES INC FBRX | Janus Henderson Group plc JHG | 657,509 9.900% | 0 (Unchanged) | Filing History |

